Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth. The post Spravato Sales Lead J&J...
On November 28-29, 2023, join us for reMind's 2nd annual Psychedelic Business Forum at the illustrious Westgate Las Vegas Resort & Casino.
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
The FDA has issued a warning letter regarding the use of ketamine outside of FDA-approved conditions. The post FDA Issues Warning Letter for Ketamine...
Recent research has shown that psychedelic drugs, including psilocybin, LSD, and MDMA, have the potential to significantly reduce depression and anxiety...
Research has shown ketamine to have rapid antidepressant effects. The post Ketamine Clinics Hope to ‘Open New Doors’ for Patients with Severe Depression...
Spravato is the only FDA-approved version of ketamine that isn't injectable. The post FDA Issues Warning Letter On Compounded Ketamine appeared first on...
Hear from experienced educators and operators on how to navigate the demanding need for education in the space of psychedelic training and therapy. Participants...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...